financetom
Business
financetom
/
Business
/
US FDA approves Neurocrine Biosciences' genetic disorder drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US FDA approves Neurocrine Biosciences' genetic disorder drug
Dec 13, 2024 3:05 PM

Dec 13 (Reuters) - The U.S. Food and Drug Administration has approved Neurocrine

Biosciences' ( NBIX ) drug to treat a type of genetic disorder, the health regulator's website

showed on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
COVID-19 triggers loss of livelihood for wedding industry employees
COVID-19 triggers loss of livelihood for wedding industry employees
Jun 29, 2021
The second wave of COVID-19 has hit several businesses severely and one among them is that of the big fat Indian weddings. CNBC-TV18’s Anu Sharma gets a ground report from Jaipur, one of the most popular spots for royal-themed destination weddings. She finds out what all has changed and what's in store.
Non-profit entity Telecom Watchdog wants govt to reject Vodafone Idea’s plea for deferring payments
Non-profit entity Telecom Watchdog wants govt to reject Vodafone Idea’s plea for deferring payments
Jul 5, 2021
Vodafone Idea can raise funds through equity sale or promoters can infuse capital which can be used for clearing dues, non-profit entity Telecom Watchdog said in a letter to telecom minister while demanding rejection of the debt-ridden company's request seeking more time to pay dues of Rs 8,292 crore. Vodafone Idea (Vi) has approached the government to seek one-year moratorium on payment of spectrum instalment of over Rs 8,200 crore, due in April 2022.
A year after TikTok ban, its Indian peers are yet to crack monetization
A year after TikTok ban, its Indian peers are yet to crack monetization
Jul 1, 2021
A host of made-in-India apps have strived to fill the void after the government banned TikTok, but none of them have reached the same scale, which made the transition tougher for popular content creators and for digital marketing
Twitter loses immunity over user-generated content in India
Twitter loses immunity over user-generated content in India
Jul 6, 2021
India's IT ministry told the High Court in New Delhi that Twitter's non-compliance amounted to a breach of the provisions of the IT Act, causing the US firm to lose its immunity, according to the filing dated July 5. The filing came in a case filed by a Twitter user who wanted to complain about some allegedly defamatory tweets on the platform, and said the company was not complying with the new law that requires the appointment of certain new executives.
Copyright 2023-2026 - www.financetom.com All Rights Reserved